Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hager A. Elbendary"'
Autor:
Ahmed E. Elsawi, Mai I. Shahin, Hager A. Elbendary, Tarfah Al-Warhi, Fatma E. Hassan, Wagdy M. Eldehna
Publikováno v:
Pharmaceuticals, Vol 17, Iss 1, p 81 (2024)
Targeting the VEGFR-2 signaling pathway is an inveterate approach toward combating pancreatic and hepatocellular cancers. Based on Sunitinib, the FDA-approved VEGFR-2 inhibitor, novel indolin-2-one-triazole hybrids were designed and synthesized as an
Externí odkaz:
https://doaj.org/article/b0471381783149de825651e3784432e9
Autor:
Elsawi, Ahmed E.1 (AUTHOR) phd.ahmed.elsawi@gmail.com, Shahin, Mai I.2 (AUTHOR) maishahin@pharma.asu.edu.eg, Elbendary, Hager A.3 (AUTHOR), Al-Warhi, Tarfah4 (AUTHOR), Hassan, Fatma E.5,6 (AUTHOR) fatma.hassan@bmc.edu.sa, Eldehna, Wagdy M.1 (AUTHOR) wagdy2000@gmail.com
Publikováno v:
Pharmaceuticals (14248247). Jan2024, Vol. 17 Issue 1, p81. 21p.